Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2011 1
2019 2
2020 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Convalescent Plasma to Treat COVID-19: A Two-Center, Randomized, Double-Blind Clinical Trial.
Ventura-Enríquez Y, Cabello-Gutiérrez C, Pérez-Calatayud ÁA, Cortina-De la Rosa E, Fareli-González CJ, Castillo-Juárez P, Carlos AP, Zavaleta-Martínez EO, Diaz-Padilla E, Murrieta S, Álvarez-Jiménez VD, Ponce-Medrano JAD, Casillas-Suárez C, Ocampo-Ocampo MA, Vargas-De-León C, Fernández-Sánchez V. Ventura-Enríquez Y, et al. Among authors: cortina de la rosa e. Life (Basel). 2022 Nov 2;12(11):1767. doi: 10.3390/life12111767. Life (Basel). 2022. PMID: 36362922 Free PMC article.
[New oral anticoagulant agents and atrial fibrilation].
Izaguirre-Ávila R, Hernández PA, Cortina-de la Rosa E. Izaguirre-Ávila R, et al. Among authors: cortina de la rosa e. Arch Cardiol Mex. 2011 Jul-Sep;81(3):163-8. Arch Cardiol Mex. 2011. PMID: 21975227 Spanish. No abstract available.
Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity.
Torres-Machorro A, Anguiano-Álvarez VM, Grimaldo-Gómez FA, Rodríguez-Zanella H, Cortina de la Rosa E, Mora-Canela S, Lerma C, García-Cruz E, Ramos-Enriquez Á, Ramirez-Marroquin S, Izaguirre-Ávila R, Rojas-Velasco G. Torres-Machorro A, et al. Among authors: cortina de la rosa e. Thromb Res. 2020 Dec;196:268-271. doi: 10.1016/j.thromres.2020.08.043. Epub 2020 Sep 1. Thromb Res. 2020. PMID: 32927400 Free PMC article.
Resource Utilization and Costs Associated With Percutaneous Coronary Intervention When Treating Patients With Acute Coronary Syndrome in the Mexican National Institute of Cardiology "Ignacio Chávez".
Jones K, Ramirez J, Papadimitropoulos M, Lomelí OS, Vanegas HR, Cortina de la Rosa E, Izaguirre Ávila R. Jones K, et al. Among authors: cortina de la rosa e. Value Health Reg Issues. 2019 Dec;20:136-141. doi: 10.1016/j.vhri.2019.02.007. Epub 2019 Aug 13. Value Health Reg Issues. 2019. PMID: 31419609
[Decrease of total hemorrhage with reduced doses of enoxaparin in high risk unstable angina. ENHNFAI study. (Enoxaparin vs non-fractionated heparin in unstable angina). Preliminary report].
Campos JV, Juárez Herrera U, Rosas Peralta M, Lupi Herrera E, González Pacheco H, Martínez Sánchez C, Chuquiure Valenzuela E, Vieyra Herrera G, Cardozo Zepeda C, Barrera Sánchez C, Reyes Corona J, Cortina de la Rosa E, de la Peña Díaz A, Izaguirre Avila R, de la Peña Fernández A. Campos JV, et al. Among authors: cortina de la rosa e. Arch Cardiol Mex. 2002 Jul-Sep;72(3):209-19. Arch Cardiol Mex. 2002. PMID: 12418296 Clinical Trial. Spanish.